In 2023, Bristol-Myers Squibb conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2023 | 2022 | 2021 | 2020 - 2017 |
---|---|---|---|---|
Total Waste Generated | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bristol-Myers Squibb’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
In 2023, Bristol-Myers Squibb generated a total of 11,479 metric tonnes of waste. a
Of this amount, 51.62% of Bristol-Myers Squibb's total waste generated was recovered through methods such as recycling, reuse, or composting, while 48.38% was disposed of through landfilling, incineration, or combustion. a
In 2023, Bristol-Myers Squibb reported a total waste generation of 11,479 metric tonnes, of which 51.62% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Bristol-Myers Squibb is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts. a
Since 2023, Bristol-Myers Squibb's total waste generation has decreased by 14.69%, suggesting improvements in operational efficiency or the early results of waste minimization strategies. a
Over the same period, Bristol-Myers Squibb's waste recovery rate increased by 12.29%. a
In 2023, Bristol-Myers Squibb generated a total of 11,479 metric tonnes of waste. a
Of this amount, 15.48% of Bristol-Myers Squibb's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 32.9% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls. The remaining 51.62% was either treated using unspecified methods or not clearly categorized. a
Since 2023, Bristol-Myers Squibb's total waste generation has decreased by 14.69%, suggesting improvements in operational efficiency or the early results of waste minimization strategies. a
Overall, Bristol-Myers Squibb's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy. a